After recruiting an AstraZeneca vet as CEO to head a new team and raising $139M cash, little Olema appears to be ready to launch … something

Sean Bohen is managing his re-entry into the R&D world in style. And he’s swerving straight into the fast lane.

A couple of weeks after …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Af­ter re­cruit­ing an As­traZeneca vet as CEO to head a new team and rais­ing $139M cash, lit­tle Ole­ma ap­pears to be ready to launch … some­thing